# Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2

> **NCT00451984** · PHASE3 · UNKNOWN · sponsor: **Aalborg University Hospital** · enrollment: 80 (estimated)

## Conditions studied

- HIV Infections
- Hepatitis A
- Hepatitis B

## Interventions

- **BIOLOGICAL:** Twinrix
- **BIOLOGICAL:** interleukin-2

## Key facts

- **NCT ID:** NCT00451984
- **Lead sponsor:** Aalborg University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2007-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00451984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00451984, "Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00451984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*